Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11690820 Methods of treating mixed dyslipidemia

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

July 4, 2023

0

Patent Application Number

174571260

Date Filed

December 1, 2021

0

Patent Citations

US Patent 10557856 Biomarkers of renal injury

0

US Patent 10576054 Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease

0

US Patent 10610508 Methods of reducing apolipoprotein C-III

0

US Patent 10966968 Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof

0

US Patent 10973797 Methods of reducing apolipoprotein c-III

0

US Patent 11033523 Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same

0

US Patent 11179362 Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy

0

US Patent 11185525 Methods of reducing apolipoprotein C-III

0

...

Patent Primary Examiner

Kevin E. Weddington

0

CPC Code

0

0

0

0

0

The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11690820 Methods of treating mixed dyslipidemia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool